Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GGCT pseudogene 3 (GGCTP3) is a processed or non-processed pseudogene located in the human genome and related to the functional gamma-glutamylcyclotransferase (GGCT) gene[3][5]. As a pseudogene, it does not encode a functional protein. No biological function or disease association has been established for GGCTP3, and it is not considered a therapeutic target. Like other pseudogenes, it may retain high sequence similarity to the parent gene but typically lacks coding potential due to mutations, insertions, or deletions. Most pseudogenes, including GGCTP3, are not transcribed or translated, though in rare cases, pseudogenes can regulate their parent gene expression via miRNA decoy activity or other mechanisms; specifically, for GGCTP3, no such role has been identified[3][5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GGCT pseudogene 3 (GGCTP3).